For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260320:nRST3767Xa&default-theme=true
RNS Number : 3767X Directa Plus PLC 20 March 2026
20 March 2026
Directa Plus plc
("Directa Plus", the "Group" or the "Company")
AIM Rule 17 and Schedule 2(g) update
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets,
announces that the following information is being disclosed pursuant to Rule
17 and Schedule 2(g) of the AIM Rules for Companies.
Sarah Cope, a Director of Directa Plus, was appointed, and remains, as a
Non-Executive Director of Eneraqua Technologies plc ("Eneraqua"), which is not
connected to Directa Plus, on 19 August 2021. On 16 March 2026, Eneraqua
appointed liquidators to undertake an insolvent Creditors Voluntary
Liquidation of Eneraqua.
For further information, please contact:
Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO
Giorgio Bonfanti, CFO
Singer Capital Markets (Nominated Adviser and Broker) +44 20 7496 3069
Rick Thompson / Phil Davies
Alma Strategic Communications (Financial PR Adviser) +44 20 3405 0205
Justine James / Hannah Campbell / Rose Docherty directaplus@almastrategic.com
About Directa Plus
Directa Plus (www.directa-plus.com (http://www.directa-plus.com/) ) is one of
the largest producers and suppliers of graphene-based products for use in
consumer and industrial markets. The Company's graphene manufacturing
capability uses proprietary patented technology based on a plasma super
expansion process. Starting from natural graphite, each step of Directa
Plus's production process - expansion, exfoliation and drying - creates
graphene-based materials and hybrid graphene materials ready for a variety of
uses and available in various forms such as powder, liquid and past
This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product,
without unwanted by-products. Directa Plus's products are made of hybrid
graphene materials and graphene nano-platelets. The products (marketed as
G+®) have multiple applications due to its properties. These G+® products
can be categorised into various families, with different products being
suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy)
and has been listed on the AIM market of the London Stock
Exchange since May 2016. The Company holds the Green Economy Mark
from London Stock Exchange which recognises companies that contribute to the
global green economy.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCAKCBQABKDAND
Copyright 2019 Regulatory News Service, all rights reserved